Comparing amidronate and immunosuppressive medications in treatment of patients with ankylosing spondylitis
Phase 2
- Conditions
- Ankylosing spondylitis.Ankylosing spondylitis
- Registration Number
- IRCT2017030813565N3
- Lead Sponsor
- Vice chancellor for research, Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 41
Inclusion Criteria
None of the patients were not received until study drug, PPD test and Viral markers were negative
Exclusion criteria: the occurrence of side-effects; Patient unwillingness to continue the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CRP. Timepoint: 0,6m. Method of measurement: labratory.;BASDAI questionnaire. Timepoint: 0,6m. Method of measurement: BASDAI questionnaire.;BASFA questionnaire. Timepoint: 0,6m. Method of measurement: BASFA questionnaire.;ESR. Timepoint: 0,6m. Method of measurement: labratory.
- Secondary Outcome Measures
Name Time Method HAQ questionnaire. Timepoint: 0,6. Method of measurement: questionnaire.